Cannabis Law Report

AUGUST 18, 2022

The firm’s deep expertise in pharmaceutical sciences, FDA regulatory compliance and pharmaceutical product liability litigation and risk management enables it to address complex legal hurdles faced by stakeholders seeking to research, develop, invest in and bring-to-market psychedelic therapies. BUFFALO, N.Y. , Aug. Tweet this.

Therapy 52

Therapy Research and Development Pharmaceutical Treatment 52

Cannabis Law Report

MARCH 22, 2023

When psychedelic therapies begin to gain regulatory approval, they will need to be incorporated into the medical billing and coding system in a way that ensures equitable patient access, say experts.

Therapy 52

Therapy Treatment Conditions Access 52

Cannabis Law Report

MAY 28, 2021

(CSE: FTRP; FTRP.WT; OTCQX: FTRPF) (“ Field Trip “), a leader in the development and delivery of psychedelic therapies, is pleased to announce that it has received conditional approval to list its common shares and warrants on the Toronto Stock Exchange (TSX). Cautionary Note Regarding Forward-Looking Information.

Conditions 98

Conditions Research and Development Therapy Events 98

Cannabis Law Report

JUNE 21, 2022

Oxygen is essential for human life and some people with breathing conditions cannot get enough oxygen by natural means. They may be in need of oxygen therapy. People who obtain oxygen therapy can often see enhanced energy levels and good sleep, and improved quality of life. Who will need oxygen therapy? cystic fibrosis.

Therapy 52

Therapy Concentrates Conditions Sleep 52

NORML

NOVEMBER 1, 2019

Those suffering from chronic pain report significant improvements in health following the passage of medical cannabis access laws, according to data published in the journal Forum for Health Economics & Policy. Among state-licensed medical cannabis registrants, two out of three report consuming cannabis to mitigate pain conditions.

Access 176

Access Patients Chronic Pain Law 176

Canna Care Docs

AUGUST 9, 2022

Thanks to a new Virginia law that went into effect on July 1, the registration process for medical cannabis patients is now quicker and less of a burden. Most states require patients to have specific qualifying conditions. What are the medical cannabis possession laws in Virginia? Virginia is different, however.

Law 105

Law Patients Legislation Conditions 105

Otherside Farms

JANUARY 3, 2023

Patients need a medical marijuana certification to use cannabis products for their health conditions. But what conditions qualify you for a medical marijuana card? Conditions That Qualify the Use of Medical Marijuana. However, as mentioned earlier, not every condition qualifies a patient to get a medical marijuana card.

Conditions 52

Conditions Chronic Pain Marijuana Patients 52

Cannabis Law Report

JUNE 16, 2021

We are excited to explore the potential of emergent psychedelic therapies. Wake is currently developing fungus-derived psilocybin and medicinal mushroom products and is making advancements in the engineering of novel psychedelic biologics, while working on proving out their safety through proprietary genetics-based integration therapies.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Veriheal

NOVEMBER 11, 2023

Simply put, in the eyes of federal law, cannabis is illegal. The Department of Veterans Affairs (VA) falls under federal government control which means it must obey all federal laws, including every cannabis law. According to Federal law, cannabis use is illegal. What Health Conditions Can Medical Cannabis Treat?

Law 62

Law Chronic Pain Conditions Legislation 62

Cannabis Law Report

MAY 19, 2022

After a psilocybin treatment,(it’s like) you’re still in your car, in traffic, but you have the windows up; the air conditioning is on and it’s quiet. became the first health centre in Canada to offer a legal psilocybin group therapy program, in which Hartle took part. It’s just you and the music.”

Therapy 52

Therapy Patients Treatment Clinical Trials 52

Cannabis Law Report

MAY 19, 2022

This is Numinus’ first psilocybin-assisted therapy treatment outside of ongoing clinical trials, and among the first to use of this regulatory mechanism through Health Canada’s Special Access Program (“SAP”), which was amended January 5 th , 2022 to include access to psychedelic compounds on a case-by-case basis.

Therapy 52

Therapy Treatment Clinical Trials Access 52

Cannabis Law Report

OCTOBER 14, 2021

International Summit on Psychedelic Therapies for Mental Illness. Why do we need psychedelic-assisted therapies? The Science of Psychedelics: Therapeutic mechanisms and clinical outcomes for a range of mental illnesses and other conditions. It’s got some big hitters. 19 and 20 November 2021. DAY 1: FRIDAY 19TH NOVEMBER.

Therapy 105

Therapy Medicine Treatment Programs 105

The Cannigma

JUNE 1, 2021

Possessing cannabis is illegal in France, although in 2020, the country changed the law so that the punishment is now a €200 fine. Possessing cannabis is illegal in France, although in 2020, the country changed the law so that the punishment is now a €200 fine. The post Cannabis laws in France appeared first on The Cannigma.

Law 113

Law Epilepsy Programs Patients 113

Cannabis Law Report

MAY 2, 2023

Says CEO, Fraser Johnson, “The clinic represents a significant milestone as […]

Therapy 52

Therapy Chronic Pain Conditions 52

NORML

MAY 19, 2020

House Bill 819 , which House members passed by a vote of 77 to 15, expands the discretion of physicians so that they can recommend cannabis therapy for “any condition” that he or she “considers debilitating to an individual patient and is qualified through his [or her] medical education and training to treat.”

Access 256

Access Therapy Patients Conditions 256

Cannabis Law Report

FEBRUARY 24, 2022

Canada recently amended its Controlled Drugs and Substances Act (CDSA) to allow for psilocybin and MDMA therapy in limited circumstances. Subsection 56(1) of the CDSA will exempt medical providers from enforcement of the CDSA when providing psilocybin and MDMA treatment to patients suffering serious or terminal health conditions.

Therapy 52

Therapy Access Clinical Trials Treatment 52

Veriheal

MARCH 12, 2024

Researchers from colleges including Oxford, Yale, John Hopkins, and Grenada polled nearly 800 people on the topic, asking them for their views on supervised psilocybin use for therapy and well-being enhancement. They were then asked to “imagine a future in which such a law has been passed at the federal level.”

Therapy 109

Therapy Decriminalization Treatment Topical 109

MMJ Recs

JANUARY 20, 2024

With a nuanced approach to medical marijuana laws, the state has embarked on a journey that seeks to balance patient well-being, regulatory oversight, and societal concerns. Let’s take a closer look at medical marijuana laws in Maryland and how they affect those in need of MMJ treatment!

Law 52

Law Marijuana Patients Chronic Pain 52

SpeedWeed

JUNE 14, 2021

State officials tasked with overseeing Ohio’s medical marijuana program approved last week the addition of three health conditions that qualify a patient to use cannabis medicinally. Spasticity is a medical condition characterized by prolonged muscle contraction and abnormal muscle tightness. List Of Conditions Reviewed Annually.

Conditions 40

Conditions Programs Therapy Patients 40

Cannabis Law Report

JULY 9, 2021

The state of the law on psychedelic substances is in flux. The use of psychedelic substances to treat mental illness and physical disorders is known as “psychedelic therapy.” Psychedelic therapy is not a fringe phenomenon. Some of the most promising substances, and the law applicable to each, are outlined below: Psilocybin.

Law 105

Law Therapy Clinical Trials Research and Development 105

MMJ Recs

JANUARY 25, 2021

Since 2016, Pennsylvania’s compassionate medical cannabis legislation, SB3, has offered those with certain medical conditions relief in the form of medical marijuana. Qualifying Medical Conditions For MMJ In Pennsylvania. Several conditions qualify you for medical marijuana in Pennsylvania. Limits On Usage.

Conditions 52

Conditions Marijuana Chronic Pain Dispensary 52

Cannabis Law Report

JULY 19, 2021

RYAH is a recognized leader in dose control technology for plant-based medicine, and we are pleased to be in a position to support the study and establish a new standardization of monitoring and measuring inhalation therapies in plant-based medicines,” said Gabriella Roda, researcher at the Department of Pharmaceuticals at the University of Milan.

Therapy 76

Therapy Data Research and Development Events 76

Cannabis Law Report

DECEMBER 5, 2021

Revenue share payments will be based on North America sales of MDMA for use in MDMA-assisted therapy, will terminate after 8 years, and include a reciprocity payment structure that reduces payments once certain financial milestones are met. The safety and efficacy of MDMA-assisted therapy is currently under investigation.

Therapy 52

Therapy Access Research and Development Clinical Trials 52

Veriheal

MARCH 10, 2021

Recently, Veriheal reported on a new law in Michigan that empowered veterinarians to discuss cannabis treatment options for their animal patients. The post Rhode Island Veterinarians May Soon Be Able to Approve Pets for Cannabis Therapy appeared first on Cannabis Central. It was a big step, and Michigan was the first state to take it.

Pets 52

Pets Therapy Treatment Chronic Pain 52

MMJ Recs

MARCH 28, 2024

With evolving laws and regulations, finding the right MMJ doctor and understanding the appointment process are crucial steps. Whether you’re new to MMJ therapy or seeking renewal, this guide aims to empower patients with the knowledge needed to navigate the MMJ landscape in Iowa effectively.

Patients 52

Patients Treatment Research and Development Therapy 52

SpeedWeed

APRIL 4, 2021

The post New York’s New Cannabis Laws Look a Lot Like Colorado’s appeared first on SpeedWeed. The marijuana industry in New York will be similar to Colorado’s, where nine years after it was legalized there are nearly 1,000 retail stores and small medical marijuana dispensaries spread across that state. View original article.

Chronic Pain 52

Chronic Pain Law Therapy Retail 52

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Image by Pfüderi from Pixabay.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

FEBRUARY 14, 2023

Marijuana Moment Hawaii senators have approved a bill in committee to promote research into the therapeutic potential of psilocybin, MDMA and other alternative treatments for mental health conditions. And a House panel separately held a hearing of a measure to create a psilocybin-focused working group.

Therapy 52

Therapy Treatment Policy Conditions 52

Veriheal

OCTOBER 30, 2023

Most importantly, the use of cannabis for recreational purposes will no longer be against the law. The legalization proposal includes other bills that outline changes in regulation, pharmacies, and health professions laws. Furthermore, the arrest will not even go on an individual’s criminal history.

Legalization 117

Legalization Therapy Decriminalization Epilepsy 117

Veriheal

NOVEMBER 9, 2023

Traditional treatments for these conditions often involve medication, physical therapy, or more invasive interventions like surgery. Refractory pain refers to pain resistant to traditional treatment approaches such as medication, physical therapy, or surgery. However, these approaches are not always practical for everyone.

Treatment 109

Treatment Therapy Research and Development THC 109

Veriheal

OCTOBER 20, 2021

Always consult a physician before attempting psychedelic therapy. Psilocybin, which is the primary chemical compound in what many call magic mushrooms , or shrooms, has gained significant traction and attention as a potential treatment for depression, anxiety, and other conditions. Cannabis and magic mushrooms for the win!

Therapy 98

Therapy Microdosing Decriminalization Consumption 98

Veriheal

MARCH 20, 2023

Alternative medicine is becoming more widely acknowledged and practiced than ever before, opening the door for therapies like psychedelics to enter the world of mainstream healthcare. Psilocybin therapy is both studied and used by highly legitimate medical establishments. Ned Lamont signed a bill (HB 5506) to fund psychedelic therapy.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

Cannabis Law Report

JULY 12, 2019

Rachel Levine today announced that effective July 20, anxiety disorders and Tourette syndrome will be approved serious medical conditions in the medical marijuana program based on the recommendation of the Medical Marijuana Advisory Board and a review of medical research on the use of marijuana to treat these conditions.

Conditions 40

Conditions Programs Research and Development Marijuana 40

Veriheal

FEBRUARY 21, 2023

Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. Many patients take MMJ for more reasons than one.

Access 98

Access Patients Chronic Pain Conditions 98

Cannabis Law Report

DECEMBER 9, 2021

AUSTIN, Texas–(BUSINESS WIRE)– Texas Original Compassionate Cultivation (TXOG), Texas’ leading medical cannabis provider, celebrates 4-year-old Carter Halliburton’s success story as he recognizes the benefits of TXOG’s medicine in navigating his rare neurological conditions.

Conditions 52

Conditions Patients Sleep Medicine 52

Cannabis Law Report

MAY 28, 2022

Husch Blackwell is the the first Am Law 100 firm to offer counsel for companies in the emerging psychedelic industry. Natasha Sumner, Kimberly Chew and Karen Luong are attorneys in Husch Blackwell LLP’s virtual office, The Link, and lead the firm’s Psychedelics & Emerging Therapies practice. Here’s the introduction.

Research and Development 52

Research and Development Therapy Clinical Trials Legalization 52

United Patients Group

NOVEMBER 21, 2023

Chronic pain affects millions of people worldwide, significantly impacting their quality of life and often leading to the development of other health conditions. This complex and multifaceted condition is linked to various medical conditions such as arthritis, fibromyalgia, neuropathy, and inflammatory disorders.

Chronic Pain 80

Chronic Pain Strains Patients Marijuana 80